The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patients

INTRODUCTION: Treatment of HCV using a combination of pegylated interferon (PEG-IFN) and ribavirin fails in about 40% of the patients with HCV genotype 4 infections, and it is physically and economically demanding. Thus, it is highly important to identify factors that can help to predict the likelih...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Ahwany, Eman, Nagy, Faten, Zoheiry, Mona, ELGhannam, Maged, Shemis, Mohamed, Aboul-Ezz, Mohamed, Zada, Suher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Electronic physician 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821316/
https://www.ncbi.nlm.nih.gov/pubmed/27054010
http://dx.doi.org/10.19082/1994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821316/
https://www.ncbi.nlm.nih.gov/pubmed/27054010
http://dx.doi.org/10.19082/1994

Ejemplares similares